Page last updated: 2024-09-04

glg-v 13 and Body Weight

glg-v 13 has been researched along with Body Weight in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Berlin, KD; Chandra, SA; Chen, CL; Chen, H; Cowell, RL; Garrison, GL; Kim, S; Lazzara, R; Qualls, CW; Roder, JD; Sangiah, S; Scherlag, BJ	1

Other Studies

1 other study(ies) available for glg-v 13 and Body Weight

Article	Year
Preliminary acute and subchronic toxicity studies of GLG-V-13, a novel class III antiarrhythmic agent, in mice. Arzneimittel-Forschung, 2000, Volume: 50, Issue:1 Topics: Animals; Anti-Arrhythmia Agents; Blood Cell Count; Blood Chemical Analysis; Body Weight; Bridged Bicyclo Compounds, Heterocyclic; Diet; Drinking; Eating; Female; Imidazoles; Lethal Dose 50; Male; Mice; Organ Size; Sex Characteristics; Time Factors	2000

Article

Year

Preliminary acute and subchronic toxicity studies of GLG-V-13, a novel class III antiarrhythmic agent, in mice.

Arzneimittel-Forschung, 2000, Volume: 50, Issue:1

Topics: Animals; Anti-Arrhythmia Agents; Blood Cell Count; Blood Chemical Analysis; Body Weight; Bridged Bicyclo Compounds, Heterocyclic; Diet; Drinking; Eating; Female; Imidazoles; Lethal Dose 50; Male; Mice; Organ Size; Sex Characteristics; Time Factors

2000